In the Media
BTV Interview with InMed CEO, Eric Adams Brief Version
InMed Files Patent Application for its Cannabinoid Biosynthesis Program
InMed Pharmaceuticals Inc. (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary biosynthesis platform technology to develop novel therapeutics for the treatment of...
Source: City Biz List
BTV: InMed Pharmaceuticals Specializes in Developing Cannabinoid-based Therapeutics
InMed Pharmaceuticals specializes in developing cannabinoid-based therapeutics to treat serious diseases with high unmet medical needs.